AT345454B - Verfahren zur herstellung eines neuen, praktisch reinen salzes eines antibiotikums - Google Patents

Verfahren zur herstellung eines neuen, praktisch reinen salzes eines antibiotikums

Info

Publication number
AT345454B
AT345454B AT228475A AT228475A AT345454B AT 345454 B AT345454 B AT 345454B AT 228475 A AT228475 A AT 228475A AT 228475 A AT228475 A AT 228475A AT 345454 B AT345454 B AT 345454B
Authority
AT
Austria
Prior art keywords
antibiotic
preparation
new
pure salt
practically pure
Prior art date
Application number
AT228475A
Other languages
German (de)
English (en)
Other versions
ATA228475A (de
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of ATA228475A publication Critical patent/ATA228475A/de
Application granted granted Critical
Publication of AT345454B publication Critical patent/AT345454B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00Antibiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT228475A 1974-03-28 1975-03-25 Verfahren zur herstellung eines neuen, praktisch reinen salzes eines antibiotikums AT345454B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB13856/74A GB1489235A (en) 1974-03-28 1974-03-28 Antibiotics
AU45499/79A AU530414B2 (en) 1974-03-28 1979-03-29 Antibiotic mm13902

Publications (2)

Publication Number Publication Date
ATA228475A ATA228475A (de) 1978-01-15
AT345454B true AT345454B (de) 1978-09-25

Family

ID=25627229

Family Applications (1)

Application Number Title Priority Date Filing Date
AT228475A AT345454B (de) 1974-03-28 1975-03-25 Verfahren zur herstellung eines neuen, praktisch reinen salzes eines antibiotikums

Country Status (13)

Country Link
JP (1) JPS582675B2 (ja)
AT (1) AT345454B (ja)
AU (2) AU499459B2 (ja)
BE (1) BE827332A (ja)
CA (1) CA1050460A (ja)
CH (1) CH626628A5 (ja)
DE (1) DE2513854C2 (ja)
FR (1) FR2265399B1 (ja)
GB (1) GB1489235A (ja)
LU (1) LU72155A1 (ja)
NL (1) NL7503672A (ja)
OA (1) OA05204A (ja)
SE (1) SE7503536L (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7704040A (nl) * 1976-04-28 1977-11-01 Merck & Co Inc Werkwijze voor het bereiden van nieuwe anti- biotica.
DK487877A (da) * 1976-11-17 1978-05-18 Merck & Co Inc Fremgangsmaade til fremstilling af et antibiotisk stof
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
EP0008885B1 (en) * 1978-09-09 1983-11-30 Beecham Group Plc Beta-lactam compounds, their preparation and use
US4530791A (en) * 1979-04-16 1985-07-23 Kowa Co., Ltd. β-Lactam antibiotics
JPS6029668A (ja) * 1983-07-28 1985-02-15 Hino Motors Ltd 経済運転ガイド装置
US20080031955A1 (en) * 2004-06-30 2008-02-07 Rijkers Marinus Petrus Wilhelm Product Comprising a Beta-Lactam Antibiotic

Also Published As

Publication number Publication date
CH626628A5 (en) 1981-11-30
ATA228475A (de) 1978-01-15
JPS582675B2 (ja) 1983-01-18
BE827332A (fr) 1975-09-29
LU72155A1 (ja) 1975-08-20
CA1050460A (en) 1979-03-13
NL7503672A (nl) 1975-09-30
DE2513854C2 (de) 1984-04-19
JPS50140692A (ja) 1975-11-11
GB1489235A (en) 1977-10-19
AU499459B2 (en) 1979-04-26
FR2265399A1 (ja) 1975-10-24
AU7959975A (en) 1976-09-30
AU530414B2 (en) 1983-07-14
AU4549979A (en) 1981-05-14
SE7503536L (sv) 1975-09-29
DE2513854A1 (de) 1975-10-02
OA05204A (fr) 1981-02-28
FR2265399B1 (ja) 1978-08-04

Similar Documents

Publication Publication Date Title
AT330353B (de) Verfahren zur herstellung eines neuen antibiotikums
ATA74575A (de) Verfahren zur herstellung von neuen d,l-n-acyltyrosinamiden
AT345453B (de) Verfahren zur herstellung eines neuen, praktisch reinen salzes eines antibiotikums
AT345981B (de) Verfahren zur herstellung von neuen 9,3'',4''- triacylestern eines antibiotikums
ATA248976A (de) Verfahren zur herstellung eines neuen antibiotikums
AT345454B (de) Verfahren zur herstellung eines neuen, praktisch reinen salzes eines antibiotikums
AT334528B (de) Verfahren zur herstellung eines neuen komplexes des antibiotikums av290
AT337899B (de) Verfahren zur herstellung von neuen derivaten eines antibiotikums
AT347050B (de) Verfahren zur herstellung eines neuen 6-mehtyl- 8beta- (substituierten)-methylergolins
AT343665B (de) Verfahren zur herstellung von neuen n4-substituierten 1,4-benzodiazepin-2-on-derivaten
AT324563B (de) Verfahren zur herstellung eines neuen antibiotikums
AT328082B (de) Verfahren zur herstellung eines neuen antibiotisch wirksamen gemisches
ATA940975A (de) Verfahren zur herstellung von neuen 2,4-disulfonamidoanilinverbindungen
AT329754B (de) Verfahren zur herstellung eines neuen antibiotikums
AT344702B (de) Verfahren zur herstellung von neuen chinoxalin-1,4-dioxyd-derivaten
AT347478B (de) Verfahren zur herstellung eines neuen piperazinopropylaminouracilsalzes
AT327383B (de) Verfahren zur herstellung eines neuen antibiotikums
AT340588B (de) Verfahren zur herstellung eines neuen antibiotikumderivates
AT337360B (de) Verfahren zur herstellung eines neuen antibiotikum-derivates
DD131823A3 (de) Verfahren zur herstellung eines neuen antibiotikums
AT349139B (de) Verfahren zur herstellung eines neuen antibiotikums
AT331423B (de) Verfahren zur herstellung von neuen desglucohellebrin-derivaten
ATA185876A (de) Verfahren zur herstellung eines neuen antibiotikums
ATA287777A (de) Verfahren zur herstellung eines neuen antibiotikums
ATA602975A (de) Verfahren zur herstellung eines neuen abtibiotikums

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
ELJ Ceased due to non-payment of the annual fee